Suppr超能文献

由RPE65基因突变引起的莱伯先天性黑蒙症患儿的光感受器层地形图。

Photoreceptor layer topography in children with leber congenital amaurosis caused by RPE65 mutations.

作者信息

Jacobson Samuel G, Cideciyan Artur V, Aleman Tomas S, Sumaroka Alexander, Windsor Elizabeth A M, Schwartz Sharon B, Heon Elise, Stone Edwin M

机构信息

Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

出版信息

Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4573-7. doi: 10.1167/iovs.08-2121. Epub 2008 Jun 6.

Abstract

PURPOSE

To study the topography of photoreceptor loss early in the course of Leber congenital amaurosis (LCA) caused by RPE65 mutations.

METHODS

Young patients with RPE65-LCA (n = 9; ages, 6-17 years) were studied with optical coherence tomography (OCT) in a wide region of central retina. Outer nuclear layer (ONL) thickness was mapped topographically and compared with that in normal subjects and in older patients with RPE65-LCA.

RESULTS

Photoreceptor layer topography was abnormal in all young patients with RPE65-LCA. Foveal and extrafoveal ONL was reduced in most patients. There were interindividual differences, with ONL thicknesses at most retinal locations ranging from near the detectability limit to a significant fraction of normal. These differences were not clearly related to age. In most patients, there was a thinner ONL inferior to the fovea compared with that in the superior retina. Summary maps obtained by aligning and averaging photoreceptor topography across all young patients showed a relative preservation of ONL in the superior-temporal and temporal pericentral retina. These retinal regions also showed the greatest magnitude of interindividual variation.

CONCLUSIONS

Photoreceptor loss in the foveal and extrafoveal retina was prominent, even in the youngest patients studied. Differences in the topography of residual photoreceptors in children with RPE65-LCA suggest that it may be advisable to use individualized ONL mapping to guide the location of subretinal injections for gene therapy and thereby maximize the potential for efficacy.

摘要

目的

研究由RPE65基因突变引起的莱伯先天性黑蒙(LCA)病程早期光感受器丧失的地形图。

方法

对9例RPE65-LCA年轻患者(年龄6 - 17岁)进行中央视网膜广泛区域的光学相干断层扫描(OCT)研究。对外核层(ONL)厚度进行地形图绘制,并与正常受试者及年龄较大的RPE65-LCA患者进行比较。

结果

所有RPE65-LCA年轻患者的光感受器层地形图均异常。大多数患者的中央凹和中央凹外ONL变薄。个体间存在差异,大多数视网膜位置的ONL厚度从接近可检测极限到正常的显著比例不等。这些差异与年龄无明显关联。大多数患者中,与视网膜上方相比,中央凹下方的ONL更薄。通过对所有年轻患者的光感受器地形图进行对齐和平均获得的汇总图显示,颞上和颞侧中央周围视网膜的ONL相对保留。这些视网膜区域的个体间差异也最大。

结论

即使在研究的最年轻患者中,中央凹和中央凹外视网膜的光感受器丧失也很明显。RPE65-LCA患儿残留光感受器地形图的差异表明,使用个体化的ONL绘图来指导基因治疗的视网膜下注射位置可能是明智的,从而最大限度地提高疗效潜力。

相似文献

1
Photoreceptor layer topography in children with leber congenital amaurosis caused by RPE65 mutations.
Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4573-7. doi: 10.1167/iovs.08-2121. Epub 2008 Jun 6.
2
Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations.
Invest Ophthalmol Vis Sci. 2009 May;50(5):2368-75. doi: 10.1167/iovs.08-2696. Epub 2008 Dec 30.
3
Retinal disease in Rpe65-deficient mice: comparison to human leber congenital amaurosis due to RPE65 mutations.
Invest Ophthalmol Vis Sci. 2010 Oct;51(10):5304-13. doi: 10.1167/iovs.10-5559. Epub 2010 May 19.
4
Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement.
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):E517-25. doi: 10.1073/pnas.1218933110. Epub 2013 Jan 22.
7
Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years.
Arch Ophthalmol. 2012 Jan;130(1):9-24. doi: 10.1001/archophthalmol.2011.298. Epub 2011 Sep 12.
8
Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success.
Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6177-82. doi: 10.1073/pnas.0500646102. Epub 2005 Apr 18.

引用本文的文献

1
Photoreceptor Disease at Ambiguous Transition Zones in Inherited Retinal Degenerations.
Transl Vis Sci Technol. 2025 Aug 1;14(8):11. doi: 10.1167/tvst.14.8.11.
2
Bisretinoid lipofuscin, fundus autofluorescence and retinal disease.
Prog Retin Eye Res. 2025 Jul 8;108:101388. doi: 10.1016/j.preteyeres.2025.101388.
3
Glial Cell Responses and Gene Expression Dynamics in Retinas of Treated and Untreated RPE65 Mutant Dogs.
Invest Ophthalmol Vis Sci. 2024 Oct 1;65(12):18. doi: 10.1167/iovs.65.12.18.
4
Differential gene expression between central and peripheral retinal regions in dogs and comparison with humans.
Exp Eye Res. 2024 Aug;245:109980. doi: 10.1016/j.exer.2024.109980. Epub 2024 Jun 22.
5
Retinoid Synthesis Regulation by Retinal Cells in Health and Disease.
Cells. 2024 May 18;13(10):871. doi: 10.3390/cells13100871.
7
Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy.
Mol Ther. 2021 Feb 3;29(2):442-463. doi: 10.1016/j.ymthe.2020.11.029. Epub 2020 Dec 3.
8
Inverse correlation between fatty acid transport protein 4 and vision in Leber congenital amaurosis associated with RPE65 mutation.
Proc Natl Acad Sci U S A. 2020 Dec 15;117(50):32114-32123. doi: 10.1073/pnas.2012623117. Epub 2020 Nov 30.
9
Voretigene Neparvovec in Retinal Diseases: A Review of the Current Clinical Evidence.
Clin Ophthalmol. 2020 Nov 13;14:3855-3869. doi: 10.2147/OPTH.S231804. eCollection 2020.
10
Retinal Structure in RPE65-Associated Retinal Dystrophy.
Invest Ophthalmol Vis Sci. 2020 Apr 9;61(4):47. doi: 10.1167/iovs.61.4.47.

本文引用的文献

1
Preliminary results of gene therapy for retinal degeneration.
N Engl J Med. 2008 May 22;358(21):2282-4. doi: 10.1056/NEJMe0803081. Epub 2008 Apr 27.
2
Effect of gene therapy on visual function in Leber's congenital amaurosis.
N Engl J Med. 2008 May 22;358(21):2231-9. doi: 10.1056/NEJMoa0802268. Epub 2008 Apr 27.
3
Safety and efficacy of gene transfer for Leber's congenital amaurosis.
N Engl J Med. 2008 May 22;358(21):2240-8. doi: 10.1056/NEJMoa0802315. Epub 2008 Apr 27.
4
Retinal laminar architecture in human retinitis pigmentosa caused by Rhodopsin gene mutations.
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1580-90. doi: 10.1167/iovs.07-1110.
5
Genetic modifiers of retinal degeneration in the rd3 mouse.
Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2863-9. doi: 10.1167/iovs.08-1715. Epub 2008 Mar 14.
6
Rpe65-/- and Lrat-/- mice: comparable models of leber congenital amaurosis.
Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2384-9. doi: 10.1167/iovs.08-1727. Epub 2008 Feb 22.
7
Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutations.
Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4759-65. doi: 10.1167/iovs.07-0453.
8
Human cone photoreceptor dependence on RPE65 isomerase.
Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15123-8. doi: 10.1073/pnas.0706367104. Epub 2007 Sep 11.
9
RDH12 and RPE65, visual cycle genes causing leber congenital amaurosis, differ in disease expression.
Invest Ophthalmol Vis Sci. 2007 Jan;48(1):332-8. doi: 10.1167/iovs.06-0599.
10
Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents.
Annu Rev Pharmacol Toxicol. 2007;47:469-512. doi: 10.1146/annurev.pharmtox.47.120505.105225.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验